Contraceptive use by women receiving chemotherapy for breast cancer

Breast

Volumn 7, Issue 3, 1998, Pages 143-149

  Valle, J ^a   Clemons, M ^a   Hayes, S ^a   Fallowfield, L ^b   Howell, A ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; AWARENESS; BREAST CANCER; CANCER CHEMOTHERAPY; CONTRACEPTION; FEMALE; HEALTH CARE; HUMAN; HUMAN EXPERIMENT; PATIENT; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR;

EID: 0031824627     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(98)90025-X     Document Type: Article

References (12)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1-15, 71-85.
2. Rose D P, Davis T E. Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet 1977; 1: 1174-1175.
3. Rose D P, Davis T E. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Res 1980; 40: 4043-4047.
4. Samaan N A, DeAsis D N, Buzdar A U, Blumenschein G R. Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy. Cancer 1978; 41: 2084-2087.
5. Bonnadonna G, Rossi A, Valagussa P et al. The CMF program for operable breast cancer with positive axillary nodes. Cancer 1977; 39: 2904-2915.
6. Schulz K D, Schmidt-Rhode P, Weymar P et al. The effect of combination chemotherapy in ovarian, hypothalamic and pituitary function in patients with breast cancer. Arch Gynecol 1979; 227: 293-301.
7. Delrio G, Placido S D, Papliarulo C et al. Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen. Tumori 1986; 72: 53-61.
8. Chapman R M. Gonadal toxicity and teratogenicity. In: Perry M C, ed. The chemotherapy source book. Baltimore: Williams & Wilkins, 1992.
9. Doll D C, Ringenberg Q S, Yarbro J W. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16: 337-346.
10. Kalter H, Warkany J. Congenital malformations. N Engl J Med 1983; 308: 424-431, 491-497.
11. Brent R L. The effects of embryonic and fetal exposure to x-ray, microwaves, and ultrasound. Clin Perinatol 1986; 13: 615-648.
12. Thirlaway K, Fallowfield L, Cuzick J. The sexual activity questionnaire: a measure of women's sexual functioning. Quality of Life Research 1996; 5: 81-90.